Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,451 | -26,740 | -12,703 | -12,216 | -8,332 |
| Depreciation Amortization | 5,501 | 4,524 | 3,801 | 3,807 | 4,483 |
| Income taxes - deferred | 37 | 18 | N/A | N/A | N/A |
| Accounts receivable | 1,725 | -1,102 | -3,546 | -1,228 | 4,766 |
| Accounts payable and accrued liabilities | -198 | -938 | 668 | -2,633 | 143 |
| Other Working Capital | 5,227 | -2,407 | -3,656 | -7,342 | 1,433 |
| Other Operating Activity | 180 | 7,688 | 6,763 | 4,349 | -10,100 |
| Operating Cash Flow | $-13,979 | $-18,957 | $-8,673 | $-15,263 | $-7,607 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,575 | -118 | -449 | -29 | N/A |
| Purchase Sale Intangibles | N/A | -13,829 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -13,829 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,575 | $-13,947 | $-449 | $-29 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -3,000 | 3,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -1,333 |
| Common Stock Issued | 434 | 6,478 | N/A | 29,942 | 1,707 |
| Common Stock Repurchased | N/A | N/A | -9 | -28 | N/A |
| Other Financing Activity | 19,171 | 19,679 | 0 | -25 | -475 |
| Financing Cash Flow | $16,605 | $29,157 | $-9 | $29,889 | $-101 |
| Beginning Cash Position | 2,321 | 6,068 | 15,199 | 602 | 8,310 |
| End Cash Position | 3,372 | 2,321 | 6,068 | 15,199 | 602 |
| Net Cash Flow | $1,051 | $-3,747 | $-9,131 | $14,597 | $-7,708 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,979 | -18,957 | -8,673 | -15,263 | -7,607 |
| Capital Expenditure | -1,575 | -131 | -449 | -29 | N/A |
| Free Cash Flow | -15,554 | -19,088 | -9,122 | -15,292 | -7,607 |